Down to Halves-Insulin Delivery System That Measures Insulin -in Half-Unit Increments Receives FDA Approval

| Jul 1, 2002

Novo Nordisk, of Princeton, New Jersey, has received approval from the U.S. Food and Drug Administration for a new insulin delivery system with a special feature and design.

The colorful NovoPen Junior, an extension of the company's NovoPen line, delivers 1 to 35 units of insulin in half-unit dose increments. It was designed for children and teenagers on insulin therapy, who typically use smaller amounts of insulin, and for adults who need the flexibility to fine-tune their insulin dosages, according to a news release from

Novo Nordisk.

-R. McLean Click Here To View Or Post Comments

Categories: Food, General, Insulin, Novo Nordisk

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Jul 1, 2002

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.